Prestige Consumer Healthcare (PBH) FY2018 results: revenue $1.0 billion, up 18.0% on the year
Prestige Consumer Healthcare Inc. (PBH) reported revenue of $1.0 billion for fiscal 2018, the year ended 31 March 2018, up 18.0% on the year before. Net income was $340 million, up 389.3%, and diluted earnings per share $6.34. The figures are the company's own, from the 10-K it filed with the SEC on 13 May 2019.
Revenue
$1.0 billion
+18.0% on the year
FY2011FY2018
Operating margin
20.7%
23.3% a year earlier
FY2011FY2018
Net income
$340 million
+389.3% on the year
FY2011FY2018
Diluted EPS
$6.34
+387.7% on the year
FY2011FY2018
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Revenue
1,041
882
806
+18.0%
Cost of revenue
465
382
339
+21.7%
Gross profit
577
500
467
+15.2%
Gross margin
55.4%
56.7%
57.9%
Operating income
216
206
260
+5.0%
Operating margin
20.7%
23.3%
32.3%
Interest expense
106
93.5
85.3
+13.6%
Pre-tax income
107
111
157
-3.4%
Income tax
-232
41.5
57.3
Effective tax rate
-217.1%
37.4%
36.4%
Net income
340
69.4
99.9
+389.3%
Net margin
32.6%
7.9%
12.4%
Diluted EPS
$6.34
$1.30
$1.88
+387.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Operating cash flow
210
149
176
+41.3%
Capital expenditure
12.5
3.0
3.6
+321.0%
Free cash flow
198
146
173
+35.6%
Free cash flow margin
19.0%
16.5%
21.4%
Cash from investing
-11.6
-695
-223
Cash from financing
-209
562
52.1
Depreciation and amortisation
33.4
25.8
23.7
+29.6%
Share-based compensation
8.9
8.1
10.0
+9.3%
Buybacks
0.0
0.0
n/a
Dividends paid
n/a
n/a
0.0
Diluted shares, weighted
54m
53m
53m
+0.3%
Balance sheet
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Shareholders' equity
1,179
823
744
+43.3%
Debt
1,993
2,194
1,625
-9.2%
Other liabilities
589
895
579
-34.2%
Total liabilities and equity
3,761
3,911
2,949
-3.9%
Fixed assets
52.6
50.6
15.5
+3.9%
Goodwill
620
615
360
+0.8%
Intangible assets
2,781
2,904
2,323
-4.2%
Cash and equivalents
32.5
41.9
27.2
-22.2%
Receivables
141
137
95.2
+3.0%
Inventory
119
116
91.3
+2.5%
Other assets
15.1
47.7
36.6
-68.4%
Total assets
3,761
3,911
2,949
-3.9%
10-K for the year ended 31 March 2018, filed 13 May 2019: the filing.